Related Experiment Video
Updated: May 21, 2026
08:49
A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
Melanoma: from mutations to medicine
Hensin Tsao1, Lynda Chin, Levi A Garraway
1Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts 02114, USA.
Genes & Development
|June 5, 2012
Summary
Recent melanoma research reveals significant breakthroughs in understanding its molecular basis and developing effective treatments. Discoveries in BRAF mutations and targeted therapies offer new hope for this aggressive cancer.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Melanoma is an aggressive, treatment-resistant human cancer.
- Early diagnosis is possible due to melanin pigment, but curative outcomes remain challenging.
- Despite numerous therapeutic strategies, few offer a high likelihood of cure beyond surgical resection.
Purpose of the Study:
- To summarize recent breakthroughs in melanoma research.
- To highlight advancements in understanding the molecular basis of melanoma.
- To discuss new therapeutic strategies and their clinical benefits.
Main Methods:
- Review of recent scientific literature and discoveries in melanoma research.
- Analysis of findings related to genetic mutations and molecular pathways.
- Evaluation of clinical efficacy of novel therapeutic approaches.
Main Results:
- Frequent mutations in BRAF(V600E) are identified as key drivers.
- The microphthalmia-associated transcription factor (MITF) pathway plays crucial oncogenic roles.
- BRAF-targeted small molecules show significant clinical efficacy.
- Emerging mechanisms of resistance to targeted therapies are being elucidated.
Conclusions:
- Recent discoveries have significantly advanced the understanding and treatment of melanoma.
- Targeted therapies, particularly those against BRAF mutations, offer clinical benefit.
- Further research into resistance mechanisms is crucial for improving long-term outcomes in melanoma treatment.
Related Concept Videos
02:18Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
01:30Skin Cancer
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:35Mutations
Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...